Drug intelligence / Profile preview

OCT-PEG-MNPs

Development stage
Preclinical
Lead developer
Peking University Cancer Hospital & Institute
Modality
Nanoparticles → Drug Delivery Systems, Peptides
Administration
Intravenous
01

Overview

OCT-PEG-MNPs is an experimental, SSTR2-targeted multimodal imaging nanoprobe comprising melanin nanoparticles coated with polyethylene glycol and surface-conjugated octreotide. Octreotide directs the nanoprobe to somatostatin receptor type 2-expressing small-cell lung cancer cells, while the melanin nanoparticle core provides intrinsic photoacoustic contrast and can chelate manganese for MRI contrast and be radioiodinated with iodine-124 for PET imaging. It was evaluated after intravenous administration in NCI-H69 small-cell lung cancer xenografts and remains a preclinical diagnostic imaging agent. ([pubs.rsc.org](https://pubs.rsc.org/nr/article/11/30/14400/652665/Multimodality-imaging-of-naturally-active-melanin))

Other names
OCT-PEG-MNPsOct-PEG-MNP
02

Targets

SSTR2 (Somatostatin receptor type 2)SSTR3 (Somatostatin receptor 3)SSTR5 (Somatostatin receptor 5)

Beyond the preview

Go deeper on OCT-PEG-MNPs.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OCT-PEG-MNPs.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call